BioCentury
ARTICLE | Financial News

ThromboGenics completes private placement

November 23, 2009 8:00 AM UTC

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium Business: Cardiovascular, Ophthalmic Date completed: 11/17/09 Type: Private placement Raised: €42.3 million ($63.3 million) Shares: 2.6 million Price...